Article
Cross-protective murine graft-versus-leukemia responses to phenotypically distinct myeloid leukemia lines.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation - 1 Jan 2000
Patterson A E, Korngold R
Abstract excerpt
A c-myc retrovirus-transformed myeloid leukemia line, MMB3.19, of C57BL/6 (B6) origin, was developed to investigate graft-versus-leukemia (GVL) activity in murine bone marrow transplantation (BMT) models. It was previously determined that both naive and leukemia-presensitized CD4+-enriched T cells are capable of mediating GVL activity to MMB3.19 challenge in both syngeneic (B6) and allogeneic (C3H.SW-->B6) strain...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
